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a7b1 is the major integrin complex expressed in dif-
erentiated muscle cells where it functions as a lami-
in receptor. In this work we have expressed the a7
ntegrin subunit in CHO cells to investigate the func-
ional properties of this receptor. After transfection
ith a7 CHO cells acquired the ability to adhere and
pread on laminin 1 consistent with the laminin recep-
or activity of the a7b1. a7 transfectants, however,
howed a 70% reduction in the ability to adhere to
bronectin and were unable to assemble a fibronectin
atrix. The degree of reduction was inversely related
o the level of a7 expression. To define the mechanisms
nderlying this adhesive defect we analyzed surface
xpression and functional properties of the a5b1 fi-
ronectin receptor. Although cell surface expression
f a5b1 was reduced by a factor of 20–25% in a7 trans-
ectants compared to control untransfected cells, this
light reduction was not sufficient to explain the dra-
atic reduction in cell adhesion (70%) and matrix as-
embly (close to 100%). Binding studies showed that
he affinity of 125I-fibronectin for its surface receptor
as decreased by 50% in a7 transfectants, indicating
hat the a5b1 integrin is partially inactivated in these
ells. Inactivation can be reversed by Mn21, a cation
nown to increase integrin affinity for their ligands.
n fact, incubation of cells with Mn21 restored fi-
ronectin binding affinity, adhesion to fibronectin,
nd assembly of fibronectin matrix in a7 transfectants.
hese data indicate that a7 expression leads to the
unctional down regulation of a5b1 integrin by de-
reasing ligand binding affinity and surface expres-
ion. In conclusion, the data reported establish the
xistence of a negative cooperativity between a7 and
5 integrins that may be important in determining
unctional regulation of integrins during myogenic
ifferentiation. © 1999 Academic Press
1 Present address: Istituto di Biologia, Università di Palermo,
taly.
2 To whom reprint requests should be addressed at the Diparti-
ento di Genetica, Biologia e Biochimia, Università di Torino, Via
antena 5bis, 10126 Turin, Italy. Fax: 39-11-6706674. E-mail:
arone@golgi.molinette.unito.it.421INTRODUCTION
Integrins are a large family of cell surface receptors
hat regulate cell-matrix adhesion and consequently
ffect several important processes such as cell prolif-
ration and differentiation [1, 2]. Expression and func-
ional properties of integrins have been investigated in
everal systems undergoing differentiation such as
eratinocytes [3], mammary epithelial cells [4], nerve
ells [5], and myogenic cells. In the latter system sev-
ral different a subunits are expressed, including a1,
3, a4, a5, a6, a7, a9, and aV. Most of these molecules
re expressed in undifferentiated myoblasts but are
own regulated during muscle cell differentiation and
annot be detected in adult skeletal and cardiac muscle
6–12]. Among these the a5b1 fibronectin receptor and
he a7b1 laminin receptor have been investigated more
xtensively.
The a5b1 integrin undergoes functional down regu-
ation in differentiating postmitotic chick embryo myo-
ytes. At this stage, a5b1 is expressed at the cell sur-
ace in an inactive form that does not support myocyte–
bronectin interaction [13]. At later stages of
ifferentiation a5b1 expression is reduced and this
olecule is absent in vivo in adult muscle cells [14–16].
own regulation of the a5b1 fibronectin receptor
eems to be important for myogenic differentiation as
hown by the fact that forced expression of an active
5b1 in quail myoblasts inhibits their differentiation,
aintaining the proliferative phase [17].
An opposite behavior has been reported for the lami-
in receptor a7b1 integrin during myogenesis. a7 in-
egrin was originally described as a cell surface marker
f striated and cardiac muscle [18] and its expression is
p regulated during muscle terminal differentiation
19, 20]. Different isoforms of this molecule are gener-
ted by alternative splicing, a7B and a7A representing
he best characterized forms. During myogenesis in
ivo, a7B appears between stage E10 and stage E13 of
ouse development and its expression increases con-
tantly up to adult stage [12, 21]. The a7A is expressed
n differentiated muscle cells and represents a specific
arker of adult striated muscle tissue [21, 22]. a70014-4827/99 $30.00
Copyright © 1999 by Academic Press























































































































422 TOMATIS ET AL.ntegrin pairs with the b1 subunit [20, 23] that also
ndergoes alternative splicing during myogenesis, the
1A isoform being expressed in the earlier phases and
1D in the late phases of differentiation [24, 25]. Dur-
ng mouse myogenesis in vivo, at developmental stages
etween E17 and newborn, a7B heterodimerizes with
oth the b1A and the b1D isoforms [12]. At this stage
f development (E17–newborn) the fibronectin receptor
5b1 is also present at the surface of differentiating
uscle cells, but, in contrast to a7, a5 integrin is down
egulated at later stages and it disappears from muscle
arcolemma during early postnatal development [16].
In this study we have transfected a7B into CHO cells
xpressing the endogenous a5b1 fibronectin receptor
ogether with either b1A or b1D isoforms. This model
imics the a7b1/a5b1 integrin expression pattern of
yogenic cells during differentiation in vitro or in vivo
rom stage E13 to newborn. Our data show that a7 is
apable of interfering with a5 function and expression
nd demonstrate the existence of a mechanism of neg-
tive cooperativity between a integrin subunits belong-
ng to the b1 group.
METHODS
Antibodies. The following antibodies were used: the rabbit poly-
lonal antibody 242 against the a7B extracellular domain [26]; rabbit
olyclonal antisera to human fibronectin and to aV, a3, a5, b1A, and
1D integrin cytoplasmic domains were previously characterized
24, 27–29]. The antiserum against the cytoplasmic domain of a7B
as prepared by immunizing rabbits with the synthetic peptide
HPILAADWHPELGPDGHPVPATA corresponding to the last 23
mino acids of mouse a7B; the aminoterminal lysine was added for
oupling to the carrier protein keyhole limpet hemocyanin. The
onoclonal antibodies PB1 to the a5b1 CHO integrin and MF20 to
arcomeric myosin were obtained from the Developmental Studies
ybridoma Bank (University of Iowa). Fluorescein-labeled goat anti-
abbit IgG, rhodamine-labeled goat anti-rabbit IgG, and peroxidase-
abeled goat anti-rabbit IgG were all from Sigma.
Transfection and integrin analysis by flow cytometry. CHO cells
ere cultured under standard conditions as previously described
29]. Stable transfectants of CHO cells expressing the human b1A or
1D were obtained as described previously [24]. cDNA coding for the
ouse a7B integrin isoform and containing the X2 exon sequence in
he extracellular domain [26] was cloned in the eukaryotic expres-
ion vector pCDNA3 (Invitrogen). CHO-b1A or CHO-b1D cells,
ransfected respectively with the human b1A or b1D subunit [24]
106 cells/50-cm2 plate), were cotransfected with 20 mg of the plasmid
ontaining a7B cDNA and 2 mg of the plasmid pECV-hyg coding for
ygromycin resistance [30], using the calcium phosphate precipita-
ion method as described in Balzac et al. [29]. After 10 days of
election in medium containing 500 mg/ml hygromycin B (Boehringer
annheim, Germany), cells expressing the transfected a7B protein
ere isolated by plating on dishes coated with 20 mg/ml laminin 1
Becton–Dickinson) for 5–10 min at room temperature. Dishes were
hen rinsed several times with PBS (10 mM phosphate buffer, pH
.3, 150 mM NaCl) to remove unbound cells. Adherent cells were
rown and subjected to repeated cycles of selection on laminin 1 to
solate cell populations expressing high levels of a7B.
The expression of a7B was assessed by flow cytometry; cells were
ncubated with the polyclonal antibody 242 against the a7B extra-
ellular domain followed by a fluorescein-conjugated secondary an-
ibody as previously described [31].ofluorescence. To detect integrin a subunit expression, cells were
urface biotinylated according to the following protocol. CHO cells
rown in monolayer were washed twice with PBS and then labeled
ith 0.5 mg/ml biotin 3-sulfo-N-hydroxisuccinimide ester (Sigma) in
anks’ buffer (1.3 mM CaCl2, 0.4 mM MgSO4, 5 mM KCl, 138 mM
aCl, 5.6 mM D-glucose, 25 mM Hepes, pH 7.4) for 15 min at 4°C.
abeling was terminated by washing three times with 0.6% BSA in
MEM, followed by three washes with Hanks’ buffer.
To analyze integrins in differentiating mouse skeletal myoblasts,
2C12 cells were plated on plastic dishes coated with 0.2% gelatin in
ulbecco’s modified Eagle’s medium with 10% FCS. At confluence,
rowth medium was replaced with Dulbecco’s modified Eagle’s me-
ium with 2% horse serum and cells were kept in culture for an
dditional 5 days to allow myotube formation. Myotubes were iso-
ated by mild trypsinization of differentiated cells under conditions
eaving myoblasts adherent to the dishes (0.005% trypsin and
.002% EDTA in PBS for 5 min at room temperature), while myo-
lasts were obtained by a second cycle of standard trypsinization.
yoblast and myotube populations were surface biotinylated in sus-
ension according to the protocol described above.
For integrin immunoprecipitation, surface-biotinylated cells were
xtracted for 20 min at 4°C with 0.5% Triton X-100 in 20 mM
ris–HCl, pH 7.4, 150 mM NaCl (TBS) with 10 mg/ml leupeptin, 4
g/ml pepstatin, and 0.1 TIU/ml aprotinin (all from Sigma). After
entrifugation at 14,000 rpm for 10 min extracts were incubated with
onimmune rabbit IgG coupled to Sepharose to remove the material
hat nonspecifically binds to the resin. Integrin complexes were
mmunoprecipitated by incubating cell extracts with a-specific anti-
odies and protein A–Sepharose beads (Pharmacia) for 15 h at 4°C
ith gentle agitation. After extensive washing, protein A–Sepharose
ound material was separated on 6% SDS–PAGE under reducing (a7
mmunoprecipitates) or nonreducing conditions (a3, a5, and aV im-
unoprecipitates) and transferred to nitrocellulose using a semidry
pparatus (Novablot; Pharmacia, Uppsala, Sweden) according to the
anufacturer’s instructions. The membranes were saturated by 1 h
ncubation at 42°C in TBS containing 5% BSA. Biotinylated proteins
ere detected by peroxidase-conjugated streptavidin and ECL (all
rom Amersham, UK).
To visualize a5b1 integrin expression myoblasts were seeded at
ow density and after 24 h either fixed or induced to differentiate for
days in DMEM with 2% horse serum. After fixation with parafor-
aldehyde and permeabilization with 0.1% Triton X-100 for 1 min at
4°C cells were stained with 5 mg/ml affinity-purified polyclonal
ntibodies to the a5 integrin cytoplasmic domain [28] followed by
hodamine-labeled secondary antibodies. Cells were also stained
ith DAPI to visualize DNA.
To analyze association of integrin a chains with b1 isoforms,
nlabeled CHO-b1A and CHO-b1D cells were extracted and immu-
oprecipitated with antibodies specific for a subunit as described
bove. After SDS–PAGE (reducing conditions) and transfer to nitro-
ellulose the coprecipitated b1 subunit isoform was detected by an-
ibodies that specifically react with the b1A or b1D integrin cyto-
lasmic domains. Peroxidase-conjugated anti-rabbit IgG was used as
econdary antibody followed by chemiluminescent substrate ECL.
To detect myosin expression in myoblasts and myotube popula-
ions, 40 mg of total protein extracts was separated by SDS–PAGE
nder reducing conditions and blotted to nitrocellulose membrane.
he membrane was then incubated in TBS containing 1% BSA and
he MF20 monoclonal antibody against sarcomeric myosin, followed
y peroxidase-conjugated anti-mouse IgG and chemiluminescent
ubstrate ECL (Amersham).
Adhesion assays. Tissue culture microtiter plates were coated by
vernight incubation at 4°C with the indicated concentration of
urified matrix proteins in PBS and postcoated with 1% BSA in PBS
or 1 h at 37°C. Fibronectin was purified from human plasma by
ffinity chromatography on gelatin–Sepharose according to Engvall
nd Ruoslathi [32]. Vitronectin was purified according to Yatohgo et










































































423CROSS-TALK BETWEEN INTEGRIN a SUBUNITSon–Dickinson. Cells at confluence were detached by incubation in 5
M EDTA in PBS for 10 min, washed twice in serum-free DMEM,
nd plated on the coated tissue culture plates for 40 min at 37°C. To
nalyze the role of Mn21, cells were plated in adhesion medium (20
M Tris, pH 7.4, 135 mM NaCl, 5 mM KCl, 2 mM L-glutamine, 1.8
M glucose, and 1% BSA) containing 1 mM MnCl2; when indicated,
he blocking monoclonal antibody PB1 at 15 mg/ml was added. Cell
dhesion was evaluated by colorimetric assay for acid phosphatase
ctivity as described in Defilippi et al. [28] and values are expressed
s percentage of the cells plated in the well.
Fibronectin matrix assembly assay. Matrix assembly in CHO
ells was evaluated by analyzing the incorporation of exogenously
dded fibronectin. Briefly, 100 nM purified human fibronectin was
dded for 15 h to confluent CHO cell monolayers grown on glass
overslips in medium containing 1% serum or in adhesion medium
20 mM Tris, pH 7.4, 135 mM NaCl, 5 mM KCl, 2 mM L-glutamine,
.8 mM glucose, and 1% BSA) in the absence or in the presence of 0.1
M MnCl2. When indicated, the monoclonal antibody PB1 was
dded at 15 mg/ml. The resulting fibronectin matrix was then visu-
lized by immunofluorescence by incubating paraformaldehyde-fixed
onolayers with 1:500 dilution of the polyclonal antibody to human
bronectin followed by rhodamine-labeled secondary antibodies.
ells were also stained with fluorescein-phalloidin (Sigma) to visu-
lize F-actin.
Matrix assembly in C2C12 cells was evaluated by measuring the
bility to organize the endogenous secreted fibronectin. Briefly,
2C12 myoblasts were seeded on 35-mm2 dishes and grown to con-
uence for 48 h in DMEM medium with 10% FCS; C2C12 differen-
iated myotubes were instead obtained by growing in differentiation
edium for 5 days as described above and the fibronectin matrix
rganization was assayed by immunofluorescence analysis.
Fibronectin binding to cells. Binding of 125I-labeled fibronectin to
HO-b1A and CHO-b1Aa7 was performed as described in O’Toole et
l. [34]. Purified bovine serum fibronectin (Gibco) was dissolved in
istilled water at 2 mg/ml. Five hundred micrograms was labeled
ith 0.5 mCi of 125I by iodogen to a specific activity of 9 3 107
pm/nmol. Cells (2 3 106) in 200 ml of Tyrode’s buffer (150 mM NaCl,
.5 mM KCl, 2 mM NaHCO3, 2 mM MgCl2, 2 mM CaCl2, 1 mg/ml
SA, and 1 mg/ml dextrose) were incubated with the specified con-
entrations of 125I-fibronectin for 1 h at 37°C in the absence or in the
resence of 1 mM MnCl2. Aliquots of 60 ml were layered on 0.3 ml of
0% sucrose and centrifuged for 3 min at 12,000 rpm. Radioactivity
ssociated with the cell pellet was determined in a gamma counter.
pecific binding was obtained by adding 10 times excess unlabeled
bronectin.
RESULTS
ransfection of a7 in CHO Cells
CHO cells expressing the human b1A or b1D inte-
rin subunits were previously characterized [24, 35].
hese cells were transfected with the full-length mouse
7B integrin cDNA using standard procedures (see
ethods) and cell populations expressing different lev-
ls of a7 were selected by multiple cycles of adhesion to
aminin 1. CHO-b1A and CHO-b1D adhere very poorly
o laminin 1 and acquire the ability to attach to this
atrix protein only after a7 transfection. As shown in
igs. 1A and 1B, CHO-b1Aa7 and CHO-b1Da7 cell
opulations with a uniform expression of a7 (mean
uorescence intensities are 93 and 87 for CHO-b1Aa7
nd CHOb1Da7, respectively) were selected after five
ycles of adhesion on laminin 1. CHO-b1Aa7 cells se-FIG. 1. (A, B, and C) Expression of integrin a7 in CHO-b1A and
HO-b1D cells. CHO cells expressing the human b1A or the human b1D
ntegrin isoforms were transfected with the mouse a7B cDNA. Cells were
elected for a7 expression by multiple cycles of adhesion to laminin 1 and
nalyzed by flow cytometry. CHO-b1Aa7 (A) and CHO-b1Da7 (B) cell
opulations after five cycles of selection on laminin 1-coated dishes. CHO-
1Aa7 cells after two cycles of selection (C). The cells were stained with a
olyclonal serum against the extracellular domain of a7 and a fluorescein-
onjugated goat anti-rabbit secondary antibody. The vertical bar repre-
ents the maximum fluorescence intensity in the negative control (CHO
ells stained with the anti a7B antibody). (D) Association of integrin a
ubunits with b1 integrin isoforms. Cells were detergent extracted and
ntegrin complexes were immunoprecipitated with antibodies specific for
5 and a7B integrin subunits. After electrophoresis under reducing condi-
ions and electrotransfer, coprecipitated b1 integrin isoforms were visual-
zed by reacting with antibodies specific to the b1A isoform or to the b1D
soform. Note that endogenous a5 and transfected a7B paired with both
















































424 TOMATIS ET AL.ected by only two cycles of adhesion to laminin 1 (Fig.
C) express a lower level of a7 (mean fluorescence
ntensity 65). Immunoprecipitation experiments fol-
owed by Western blotting showed that the transfected
7 integrin paired both with the b1D and with the b1A
soform (Fig. 1D). Similar results were obtained for the
5 integrin subunit showing that both a7 and a5 sub-
nits associated to the b1 isoforms in a similar fashion.
dhesive Properties of a7 Transfected Cells
To test adhesive properties of a7-expressing cells, we
erformed adhesion assays on dishes coated with pu-
ified matrix proteins. While untransfected CHO-b1A
ells showed undetectable adhesion to laminin 1, a7
ransfectants strongly adhered to laminin 1 and the
ercentages of adherent CHO-b1Aa7 and CHO-b1Da7
ells were not significantly different (Fig. 2A).
In contrast, transfectants expressing high levels of
7 showed a 70% reduction in the ability to adhere to
bronectin compared to control cells (Fig. 2B). Reduc-
ion in cell adhesion to fibronectin was proportional to
he a7 expression level; in fact, only 40% reduction in
dhesion to fibronectin was observed in the cell popu-
ation expressing low level of a7 (Fig. 2B). The reduced
dhesion to fibronectin did not reflect a general defect
n cell adhesion since all cell types analyzed adhered
ormally and comparably when plated on vitronectin-
oated dishes (Fig. 2C). Moreover, this effect was not a
ransfection artifact because the reduction of adhesion
o fibronectin occurred not in one single clone, but in
ell populations from two independent transfections.
n CHO cells adhesion to fibronectin is mediated by the
ndogenous a5b1 integrin as shown by inhibition with
he monoclonal antibody PB1 specific for this integrin
omplex (Fig. 2B). These data suggest a specific inhib-
tory effect of a7 expression on the fibronectin receptor
5b1.
rganization of Fibronectin Matrix in a7 Transfected
CHO Cells
To test if functional properties of a5b1 are altered in
7 transfectants we analyzed fibronectin matrix as-
embly by immunofluorescence staining.
CHO cells assemble a very poor endogenous fibronec-
FIG. 2. Adhesion of a7-transfected CHO cells on purified matrix
roteins. Microtiter wells were coated with increasing concentration
f mouse laminin 1 (A), human plasma fibronectin (B), or human
lasma vitronectin (C). Cells were suspended by EDTA treatment
nd plated in serum-free medium for 40 min at 37°C. Cell adhesion
as measured as described under Methods and the mean values
rom triplicate measurements are presented. CHO-b1Aa7 (■) and
HO-b1Da7 (F) expressing high levels of a7 (see Figs. 1A and 1B),
HO-b1Aa7 (Œ) expressing low a7 level (see Fig. 1C). CHO-b1A cells
ither in the absence (—E—) or in the presence (- - -E - - -) of the







































425CROSS-TALK BETWEEN INTEGRIN a SUBUNITSin matrix, but are able to organize exogenously added
bronectin in fibrils on their apical surface [36]. Figure
A shows fibronectin matrix assembly in CHO-b1A
onolayer cells incubated overnight with 100 nM pu-
ified human fibronectin. This process is driven by
5b1 integrin, as shown by inhibition with the a5b1-
locking PB1 monoclonal antibody (Fig. 3B). When
HO-b1Aa7 cells were tested, lack of fibronectin ma-
rix assembly was observed (Fig. 3C) as judged by the
uorescence staining. A similar defect in matrix as-
embly was observed also in a7b1D-expressing cells
Fig. 3D). The use of higher fibronectin concentrations
up to 300 nM) or longer incubation times (24 h) did not
ignificantly increase matrix assembly in a7 transfec-
ants.
Thus, both adhesion and matrix assembly assays
ndicate a functional down regulation of the a5b1 fi-
ronectin receptor in cells expressing the a7b1 laminin
eceptor.
FIG. 3. Fibronectin matrix organization in a7-transfected CHO c
HO-b1Da7 (D) cells were cultured for 15 h with 100 nM exogenous h
f the blocking a5b1 monoclonal antibody PB1 (B). Fibronectin org
taining as described under Methods. Note that fibronectin matri
HO-b1Da7 cells (D). Bar, 300 mm.xpression of Integrin a Subunits in a7 Transfectants
To investigate the mechanisms leading to reduced
bronectin adhesion and matrix assembly, we ana-
yzed surface expression of the a5 and of the other a
ntegrin subunits before and after a7 transfection.
Cell-surface-biotinylated proteins were immunopre-
ipitated from CHO-b1A and CHO-b1Aa7 using poly-
lonal antibodies against a3, a5, a7B, and aV, which
epresent the major a integrin subunits in these cells.
s shown in Fig. 4A a 25% reduction in surface expres-
ion of a5 was observed in a7 transfectants as quanti-
ated by densitometric scanning of gel bands. The sur-
ace expression of a5b1 integrin was further analyzed
y flow cytometry with PB1 monoclonal antibody (Fig.
B). The mean fluorescence intensity was reduced by
3% in CHO-b1Aa7 compared to CHO-b1A (mean flu-
rescence values were 102 and 133, respectively).
hese differences in a5b1 integrin surface expression
. Confluent monolayers of CHO-b1A (A and B), CHO-b1Aa7 (C), and
an plasma fibronectin in the absence (A, C, and D) or in the presence
ized on the cell monolayer was visualized by immunofluorescence


























426 TOMATIS ET AL.ere further confirmed by fibronectin binding studies
see below).
a3b1 subunit was also slightly decreased in surface
xpression in a7 transfectants, while no significant
hanges were detected for aVb3 integrin (Fig. 4A).
inding of Fibronectin to a7 Transfected Cells
The decreased a5b1 expression observed in a7 trans-
ectants is relatively small compared to the dramatic
FIG. 4. Reduction in the surface expression of a5 in a7-transfecte
mmunoprecipitated with anti-a7B, -a5, -a3, and -aV polyclonal ant
recipitate was separated by SDS–PAGE under reducing conditions
3, and aV were separated under nonreducing conditions. Proteins
nd then detected by ECL. The positions of the a and the coprecipit
HO-b1A (top) and CHO-b1Aa7 cells (bottom). Cells were stained wi
nti-mouse secondary antibody. The vertical bar represents the ma
tained only with the secondary antibody).eduction in cell adhesion or matrix assembly. In order
o test the possibility that fibronectin binding affinity
as altered in a7 transfectants, we examined the bind-
ng of 125I-fibronectin to CHO-b1A and CHO-b1Aa7
ells kept in suspension. The data shown in Fig. 5
ndicate a reduced fibronectin binding in a7-expressing
ells. Scatchard analysis allowed the definition of ap-
arent dissociation constants of 2.8 3 1027 M for CHO-
1A cells and of 5.7 3 1027 M for CHO-b1Aa7 cells,
HO cells. (A) Surface-biotinylated CHO-b1A and CHO-b1Aa7 were
dies. To resolve the a7 subunit from comigrating b1, a7B immuno-
transferred to nitrocellulose membrane. Immunoprecipitates of a5,
e visualized by incubation with peroxidase-conjugated streptavidin
d b subunits are indicated. (B) Flow cytometry detection of a5b1 in
he anti-a5b1 monoclonal antibody PB1 and a rhodamine-conjugated



















































































427CROSS-TALK BETWEEN INTEGRIN a SUBUNITShus indicating that upon a7 transfection, the binding
ffinity of the fibronectin receptor for its ligand is re-
uced by 50%. Incubation of the CHO-b1Aa7 cells with
n21, a divalent cation known to increase ligand bind-
ng affinity of several integrins [37] restored the bind-
ng affinity to values comparable to those observed in
HO-b1A cells (Kd 5 3.1 3 10
27 M). The x intercept in
he Scatchard plot indicated that the number of fi-
ronectin binding sites did not change significantly in
he presence of Mn21 (1.70 3 105 binding sites for
HOb1Aa7 and 1.8 3 105 for CHO-b1Aa71Mn21), con-
rming that this cation affects mainly the integrin
igand binding affinity.
Scatchard analysis also confirmed reduced expres-
ion of the fibronectin receptor in a7 transfectants. The
umber of fibronectin binding sites was 2.1 3 105 for
HO-b1A and 1.70 3 105 for CHO-b1Aa7 (19% reduc-
ion).
ffect of Mn21 Ions on Adhesion and Matrix Assembly
in a7 Transfectants
Based on the results described above we tested
hether Mn21 ions can rescue the adhesive phenotype
f a7 transfectants. As shown in Fig. 6A, when CHO-
1Aa7 were incubated with 1 mM Mn21, adhesion to
bronectin-coated dishes was restored to levels close to
FIG. 5. Binding of 125I-fibronectin to a7-transfected CHO cells.
ncreasing concentrations of 125I-fibronectin (9 3 107 cpm/nmol) were
ixed with 2 3 106 cells in a total volume of 200 ml for 1 h at 37°C.
0-ml aliquots were layered on 0.3 ml of 20% sucrose and centrifuged.
adioactivity associated with the cell pellet was determined in a
amma counter. CHO-b1A (E), CHO-b1Aa7 (■), and CHO-b1Aa7 in
he presence of 1 mM Mn21 (Œ). Specific binding was obtained by
ubtracting values obtained in the presence of 10-fold excess cold
bronectin. The mean values from triplicates are reported.hose observed in untransfected cells. When the a5b1-
locking monoclonal antibody PB1 was added together
ith Mn21, CHO-b1Aa7 no longer adhered to fibronec-
in, showing that Mn21-stimulated adhesion to fi-
ronectin specifically involves a5b1 integrin.
We then tested whether fibronectin assembly ability
f CHO-b1Aa7 can be modified by Mn21. As shown in
ig. 6B treatment of cell monolayer with 0.1 mM Mn21
as sufficient to restore the ability of a7 transfectants
o assemble fibronectin fibrils at the apical surface, and
n21 effect was blocked by PB1 monoclonal antibody,
onfirming specific involvement of a5b1 in this process.
These results demonstrated that on the surface of
HO-b1Aa7 cells the integrin a5b1 exists in an inac-
ive state, likely due to a change in the molecular
onformation, which can be reverted by Mn21 treat-
ent.
ibronectin Matrix Assembly and a5b1 Expression in
Differentiating C2C12
In order to test whether the negative cooperativity
bserved between a7 and a5 integrins was unique of
HO transfectants we analyzed mouse myogenic cells
hat normally express these integrin heterodimers.
ndifferentiated C2C12 myoblasts in vitro synthesize
nd assemble on their apical surface a dense fibronec-
in matrix (Fig. 7A, a). Upon serum withdrawal C2C12
ells start to differentiate and after 5 days large
ultinucleated myotubes are formed (Fig. 7A, d).
hese myotubes failed to organize fibronectin matrix
Fig. 7A, b) as shown by immunofluorescence staining
nd rather organized a laminin network (our unpub-
ished results; see also [43]). Lack of fibronectin assem-
ly was not due to lack of synthesis since fibronectin is
till produced and assembled by undifferentiated myo-
lasts present in the culture (Fig. 7A, b).
Analysis of integrin expression by immunoprecipita-
ion of surface-biotinylated differentiating C2C12 indi-
ated that myotubes express levels of a5b1 integrin at
heir surface not significantly lower than those de-
ected on undifferentiated myoblasts (Fig. 7B). a5b1
ntegrin expression on differentiated myotubes was
lso confirmed by immunofluorescence experiments
Fig. 8). In addition a7 expression is up regulated in
ifferentiated cells (Fig. 7B), suggesting that, also dur-
ng myogenic differentiation, high a7 expression level
eads to functional down regulation of a5b1 function.
DISCUSSION
In this study we analyzed CHO cells transfected with
he laminin-binding, muscle-specific a7B integrin. The
esults reported here reveal the existence of a negative
ooperativity between the muscle-specific a7b1 laminin
eceptor and the a5b1 fibronectin receptor. In fact, the























































428 TOMATIS ET AL.own regulation of the endogenous a5b1 fibronectin
eceptor resulting in a strong decrease of cell adhesion
o fibronectin and of the ability to assemble a fibronec-
in matrix. The decrease in cell adhesion to fibronectin
as inversely related to the level of a7 surface expres-
ion. Moreover, inhibition of fibronectin matrix assem-
ly was nearly complete as judged by immunofluores-
ence staining intensity. Since antibody inhibition
tudies indicated that adhesion to fibronectin and ma-
rix assembly are supported by the endogenous a5b1
ntegrin, we investigate the expression of this molecule
y immunoprecipitation, flow cytometry, and ligand
inding studies. These analyses consistently showed
hat a5b1 expression was reduced by 20–25% in a7-
xpressing CHO cells. A reduction of a5 surface expres-
ion after overexpression of a7B in human epithelial
idney 293 cells was observed also by Echtermeyer et
l. (submitted for publication).
The limited extent of reduction in a5b1 surface ex-
ression (20–25%) can hardly explain the strong re-
uction of cell adhesion and matrix assembly
70–100%) occurring in a7-transfected CHO. Measure-
ents of fibronectin binding to the cell surface indi-
ated that upon a7 transfection fibronectin binds with
n affinity that is 50% lower compared to untrans-
ected cells, indicating that a5b1, although expressed
t the cell surface, is partially inactivated by the pres-
nce of the a7b1 integrin heterodimer. The reduction of
bronectin binding affinity can be almost completely
ecovered by Mn21 treatment. This cation is known to
ncrease ligand binding affinity of several integrin com-
lexes by changing the conformation of the integrin
omplex ectodomain [38]. The ability of Mn21 to restore
bronectin binding affinity clearly indicates that the
5b1 is functionally inactivated in a reversible manner
nd suggests that conformational changes occurring in
he receptor are responsible for the reduced binding
ffinity.
These data suggest that the functional down regula-
ion of the a5b1 integrin occurring in a7 CHO trans-
ectants can be explained by the concomitant reduction
FIG. 6. Mn21 treatment restores adhesion (A) and matrix assem-
ly (B) of CHO-b1Aa7 transfectants. (A) Cells were suspended by
DTA treatment and plated in serum-free or adhesion medium (see
ethods) for 40 min at 37°C. CHO-b1A (E), CHO-b1Aa7 (■), CHO-
1Aa7 cells in presence of Mn21 (F), CHO-b1Aa7 cells in presence of
n21 and of monoclonal antibody PB1 (Œ). The reduced adhesion of
HO-b1Aa7 cells was restored to levels observed in untransfected
ells by adding Mn21 during adhesion. Blocking the a5b1 integrin
ith monoclonal antibody PB1 abolished adhesion of Mn21-treated
ells. (B) Confluent monolayers of CHO-b1Aa7 cells were cultured
or 15 h with 100 nM exogenous human plasma fibronectin either in
he absence (a) or in the presence of (b) 0.1 mM MnCl2 or (c) 0.1 mM
nCl2 and the blocking monoclonal antibody PB1. Fibronectin ma-
rix was detected by immunofluorescence. Note that Mn21 treatment
estores fibronectin matrix assembly in CHO-b1Aa7 cells (b) in a








































































































































































































































































































































































































































































































































































































430 TOMATIS ET AL.f surface expression and binding affinity. The reduc-
ion in binding affinity plays an important role in the
unctional down regulation since Mn21 treatment of a7
ransfectants restores cell adhesion to fibronectin and
atrix assembly to levels close to those of a7-negative
ells.
The understanding of the mechanisms by which a7
xpression leads to reduced a5b1 expression and bind-
ng affinity deserves further work. A possible explana-
ion for the reduced a5 surface expression can be the
ompetitive recruitment of b1 subunit by the endoge-
ous a5 and the transfected a7 integrins. This possi-
ility is suggested by the fact that reduced expression
ccurred for a subunits associated with b1, but not for
Vb3 heterodimers (see Fig. 4). More complex mecha-
isms are likely to be responsible for the reduced li-
and binding. This function is known to be regulated
oth by intracellular signals [2] and by association
ith other membrane proteins like the recently de-
cribed CD98 antigen [39]. Thus it is possible that a7
ffects one of such pathways. Interestingly the a7b1A
nd a7b1D heterodimers were found to have similar
ffects on the a5b1 complex inactivation, suggesting
hat this effect is specifically mediated by the a7 sub-
nit.
Previous work demonstrated that a given integrin
ay negatively regulate another integrin complex. For
xample, expression of aVb3 in K562 cells inhibits the
hagocytic function of the endogenous a5b1 [40]. Sim-
larly, transfected aIIbb3 inhibits the function of co-
ransfected a2b1 or endogenous a5b1 in CHO cells [41]
nd activation of LFA-1 on T cell surface decreases
FIG. 8. Expression of a5b1 integrin at the cell surface of C2C12 m
ncubated with differentiation medium for 5 days (C and D). After fix
ntibodies to the cytoplasmic domain (A and C). Cells in A were ph
tained for DNA with DAPI to visualize nuclei (D). Bar, 15 mm.dhesion mediated by a4b1 [42]. In all these examples
unctional interference occurs between integrin belong-
ng to different classes and in particular b3 or b2
ntegrins affect b1 class heterodimers. The a7 effect
eported in the present study differs from those dis-
ussed above since in our case the interference occurs
etween heterodimers belonging to the same b1 class.
hile in the previous cases the b subunits are thought
o be involved in the generation of an inhibitory sig-
als, in our case the a7 subunit is responsible for this
ffect. We, thus, believe that the current example rep-
esents a novel mechanism of negative cooperativity
etween different heterodimers sharing the same b
ubunit.
The possible physiological significance of the nega-
ive interference of a7b1 on a5b1 integrin is suggested
y the functional behavior of these integrins during
yogenesis. It has been shown that mononucleated
yoblasts assemble a dense fibronectin matrix, but
his property is lost in multinucleated myotubes [43,
4]. In vitro differentiation of myogenic cells, however,
oes not involve loss of a5b1 surface expression as
hown by immunoprecipitation experiments [13, 45,
6]. By analyzing C2C12 myogenic cells we have con-
rmed loss of fibronectin matrix assembly in myotubes
ithout appreciable loss of a5b1 integrin expression
see Figs. 7 and 8). These data suggest that the fi-
ronectin receptor is functionally inactivated in differ-
ntiated muscle cells. This interpretation is also sup-
orted by the work of Boettiger et al. [13], who showed
hat chicken postmitotic myocytes have reduced capac-
ty to adhere to fibronectin compared to undifferenti-
blasts and myotubes. Cells were seeded at low density (A and B) and
on and permeabilization a5 integrin was visualized with polyclonal






































431CROSS-TALK BETWEEN INTEGRIN a SUBUNITSted myoblasts. This lack of function can be rescued by
reating myocytes with an a5-activating monoclonal
ntibody, indicating that the a5b1 integrin is exposed
t the myocyte surface in an inactive conformation.
Concomitantly with decreased a5b1 integrin func-
ion a strong increase in a7 integrin subunit expression
ccurs during myogenesis [12, 19, 20, 22] (Fig. 7 this
ork). Our results in CHO cells suggest that a7 inte-
rin can be responsible for the functional down regu-
ation of the fibronectin receptor during myogenesis.
The authors thank Helga von der Mark for providing the 242
ntiserum to the extracellular domain of a7 and Paola Caudana for
elping in some of the experiments. This work was supported by
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